Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Other Operating Expenses (2017 - 2025)

Haemonetics has reported Other Operating Expenses over the past 13 years, most recently at $11.6 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $11.6 million for Q4 2025, down 4.75% from a year ago — trailing twelve months through Dec 2025 was $31.1 million (down 46.6% YoY), and the annual figure for FY2024 was $2.0 million, up 423.56%.
  • Other Operating Expenses for Q4 2025 was $11.6 million at Haemonetics, down from $19.8 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for HAE hit a ceiling of $19.8 million in Q3 2025 and a floor of -$11.7 million in Q1 2025.
  • Median Other Operating Expenses over the past 5 years was $10.5 million (2021), compared with a mean of $8.6 million.
  • Biggest five-year swings in Other Operating Expenses: surged 1790.58% in 2023 and later tumbled 162.23% in 2025.
  • Haemonetics' Other Operating Expenses stood at $9.6 million in 2021, then tumbled by 96.02% to $382000.0 in 2022, then soared by 1709.16% to $6.9 million in 2023, then surged by 76.96% to $12.2 million in 2024, then fell by 4.75% to $11.6 million in 2025.
  • The last three reported values for Other Operating Expenses were $11.6 million (Q4 2025), $19.8 million (Q3 2025), and $11.4 million (Q2 2025) per Business Quant data.